ArticlePediatric cardiology2026
Associations of Overweight and Obesity Indicators with Cardiometabolic Risk Profile in Children and Adolescents with Congenital Heart Disease.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to compare the cardiometabolic risk profile between overweight or obese and normal weight and to investigate the influence of overweight and obesity indicators on cardiometabolic risk profile in children and adolescents with congenital heart disease (CHD). A cross-sectional study with 232 children and adolescents with CHD. Cardiometabolic risk profile were evaluated: high-density lipoprotein cholesterol (HDL-c), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-c), non-HDL-c, fasting glucose, triglycerides, high-sensitivity C-reactive protein (hs-CRP), and systolic and diastolic blood pressure (SBP and DBP). Overweight and obesity indicators included body fat percentage (%BF) by air displacement plethysmography and waist circumference percentile (WC-p) and were categorized in "overweight or obese children and adolescents" versus "normal weight children and adolescents". Data were examined using linear regressions. In linear regression analysis, WC-p was inversely associated with HDL-c (ß: - 0.19, 95% CI - 0.16; - 0.03) and directly associated with hs-CRP (ß: 0.02, 95% CI 0.02; 0.03). %BF was directly associated with LDL-c (ß: 0.38, 95% CI 0.00;0.75), non-HDL-c (ß: 0.42, 95% CI 0.02;0.81), hs-CRP (ß: 0.02, 95% CI 0.01; 0.02), SBP (ß: 0.26, 95% CI 0.13;0.39) and DBP (ß: 0.15, 95% CI 0.07;0.23). When stratified by overweight or obese children and adolescents versus normal weight children and adolescents, WC-p and %BF were directly associated hs-CRP (ß:0.14, 95%CI 0.03;0.26 and ß:0.02, 95%CI 0.01; 0.04, respectively) and %BF was also directly associated with TC (ß:1.68, 95%CI 0.30;3.07), LDL-c (ß:1.64, 95%CI 0.32;2.95), non-HDL-c (ß:1.56, 95%CI 0.12;3.01) in overweight or obese children and adolescents. The increase in WC-p and %BF seems to increase the risk of altered cardiometabolic risk profile, especially in the overweight or obese children and adolescents. Early identification of overweight or obesity indicators may allow timely intervention to prevent adverse cardiovascular outcomes in adulthood.
Indexed as
Identifiers
42113240What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.